PHARMA HOLDING ApS Financials, key figures and credit report
Gross profit - 198.2 kDKK FY 2025 -1,154.6% vs 2024
EBIT - 759.4 kDKK FY 2025 -4,706.9% vs 2024
Net debt 264.3 kDKK FY 2025 -2% vs 2024
Quick ratio 0.1 FY 2025 -0.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -11.77 | -14.47 | -1.80 | -15.80 | - 198.20 |
| Gross profit | -11.77 | -14.47 | -1.80 | -15.80 | - 198.20 |
| Other operating expenses | - 561.19 | ||||
| EBIT | -11.77 | -14.47 | -1.80 | -15.80 | - 759.39 |
| Other financial income | 0.02 | 0.13 | 0.04 | ||
| Other financial expenses | -25.14 | -2.49 | -1.27 | -2.66 | |
| Reduction non-current investment assets | -2 445.38 | -0.00 | |||
| Income from other inv. held as non-curr. assets | 5.33 | 14.27 | -13.61 | -2.89 | |
| Net income from associates (fin.) | 239.53 | - 445.51 | 374.70 | -2 038.08 | - 188.95 |
| Pre-tax profit | 207.96 | - 448.21 | -2 087.33 | -2 059.31 | - 948.31 |
| Income taxes | 8.01 | -0.02 | 0.44 | -6.95 | |
| Net earnings | 215.97 | - 448.23 | -2 086.89 | -2 059.31 | - 955.26 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 2 297.84 | 1 852.33 | 2 227.03 | 188.95 | |
| Investments total | 2 297.84 | 1 852.33 | 2 227.03 | 188.95 | |
| Non-current loans receivable | 4 172.14 | 4 222.14 | 1 776.76 | 1 776.76 | 1 780.48 |
| Long term receivables total | 4 172.14 | 4 222.14 | 1 776.76 | 1 776.76 | 1 780.48 |
| Inventories total | |||||
| Current other receivables | 1.00 | 0.00 | 1.00 | 1.00 | 10.26 |
| Current deferred tax assets | 73.46 | 90.00 | 58.00 | 42.00 | |
| Short term receivables total | 74.46 | 90.00 | 59.00 | 43.00 | 10.26 |
| Other current investments | 5.95 | 20.21 | 6.61 | 3.72 | |
| Cash and bank deposits | 69.53 | 1.08 | 81.81 | 63.17 | 37.51 |
| Cash and cash equivalents | 75.48 | 21.30 | 88.42 | 66.89 | 37.51 |
| Balance sheet total (assets) | 6 619.91 | 6 185.77 | 4 151.22 | 2 075.60 | 1 828.25 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 57.20 | 58.90 | |||
| Other reserves | 2 172.84 | 1 727.33 | 2 102.03 | 63.95 | |
| Retained earnings | 3 940.79 | 4 543.37 | 3 720.44 | 3 671.63 | 1 676.28 |
| Profit of the financial year | 215.97 | - 448.23 | -2 086.89 | -2 059.31 | - 955.26 |
| Shareholders equity total | 6 436.80 | 5 931.37 | 3 785.58 | 1 726.28 | 771.02 |
| Provisions | 561.19 | ||||
| Non-current liabilities total | |||||
| Current trade creditors | 10.00 | 10.00 | 10.00 | 194.28 | |
| Current owed to participating | 180.65 | 180.83 | |||
| Current owed to group member | 122.21 | 109.19 | 176.43 | 155.93 | 120.93 |
| Short-term deferred tax liabilities | 17.45 | 0.00 | |||
| Other non-interest bearing current liabilities | 43.45 | 135.20 | 179.20 | 2.74 | 0.00 |
| Current liabilities total | 183.11 | 254.39 | 365.63 | 349.32 | 496.04 |
| Balance sheet total (liabilities) | 6 619.91 | 6 185.77 | 4 151.22 | 2 075.60 | 1 828.25 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated